Yu HA, Goto Y, Hayashi H, Felip E, et al. HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy. J Clin Oncol 2023 Sep 10:JCO2301476. doi: 10.1200/JCO.23.01476.
PMID: 37689979